Businessweek.com:TransTech Pharma Inc. and Forest Laboratories Inc. said Tuesday they entered a license agreement potentially worth more than $1.1 billion for the development of diabetes drugs.
Under the deal, Forest will pay privately held TransTech $50 million upfront and more than $1.1 billion if the drugs meet certain development and commercial milestones...continue
Posts
No comments:
Post a Comment